439P Trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2+ metastatic breast cancer (mBC) and active brain metastases (BM): Final analysis of DESTINY-Breast07 (DB-07)
Makaleler > Tam Makale · 2026
Yazarlar: C. Anders, K. Jhaveri, S. Loi, E.P. Hamilton, P. Schmid, E. Gokmen, S-A. Im, C. Karacin, C.H.E. Barrios, Y.H. Park, S. Topalolu, S. Boston, A. Konpa, S. Mondal, F. André
ESMO Open, Uluslararası, Wos, 2026, cilt 11, ss 107462-107462